Clinical Trials on Lichen Planus Pigmentosus in Poland

Total 190 results

Wroclaw Medical University

Completed

Evaluation of the Effectiveness of Photodynamic Therapy in the Treatment of Lesions of the Lichen Planus Type in the Oral Mucosa and Its Diagnostics With the Use of Autofluorescence, in Various Wavelength Ranges, in Combination With the Use of Texture Analysis and Fractal Dimension

Oral Lichen Planus

Poland
Novartis Pharmaceuticals

Completed

PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus (PRELUDE)

Lichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen Planopilaris

Germany, United States, France
Wroclaw Medical University

Completed

Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus

Lichen Planus, Oral

Poland
Incyte Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Cutaneous Lichen Planus

United States, Canada
Stanford University
Icahn School of Medicine at Mount Sinai; University of Michigan; The Cleveland... and other collaborators

Terminated

Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus

Lichen Planus

United States
Kiniksa Pharmaceuticals, Ltd.

Completed

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Plaque Psoriasis | Chronic Idiopathic Urticaria | Lichen Planus | Lichen Simplex Chronicus | Chronic Idiopathic Pruritus

United States
Medical University of Warsaw

Recruiting

Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy

Peanut Allergy

Poland
Medical University of Warsaw

Recruiting

High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety

Peanut Allergy

Poland
Medical University of Warsaw
Warsaw Clinical University Center

Unknown

Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Nephrectomy/Nephron Sparing Surgery(NSS) Performed Via Lumbotomy

Erector Spinae Plane Block

Poland
Medical University of Warsaw

Completed

Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Laparoscopic Nephrectomy/Nephron Sparing Surgery (NSS)/Hynes-Anderson Procedures.

Erector Spinae Plane Block

Poland
Medical University of Warsaw
University College, London; Queen Mary University of London; National Science...

Recruiting

Comprehensive Assessment of Morphometric, Functional, Biomechanical and Biological Interactions Between Atherosclerotic Plaque and Platelets Within the Stenosed Coronary Artery (INTERFORCE)

Atherosclerosis | Chronic Coronary Syndrome

Poland
Applied Genetic Technologies Corp

Completed

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)

X-Linked Retinitis Pigmentosa

United States
Medical University of Warsaw
Nutricia Foundation; Thermo Fisher Scientific, Inc

Recruiting

Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food Allergy

Atopic Dermatitis | Peanut Allergy | Food Allergy | Tree Nut Allergy

Poland
Almirall, S.A.

Terminated

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis (MODIFY)

Plaque Psoriasis

Poland
Pomeranian Medical University Szczecin

Unknown

Stem Cells Therapy in Degenerative Diseases of the Retina

Retinal Degeneration | Retinitis Pigmentosa | Age Related Macular Degeneration | Stargardt Disease 1

Poland
Biogen

Completed

A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112 (XIRIUS)

X-Linked Retinitis Pigmentosa

United States, United Kingdom
Beacon Therapeutics

Active, not recruiting

Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (HORIZON)

X-Linked Retinitis Pigmentosa

United States
4D Molecular Therapeutics

Active, not recruiting

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

X-Linked Retinitis Pigmentosa

United States
Beacon Therapeutics

Active, not recruiting

A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)

X-Linked Retinitis Pigmentosa

United States
Endogena Therapeutics, Inc

Active, not recruiting

Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa

Retinitis Pigmentosa | Retinitis Pigmentosa Syndrome

United States
Beacon Therapeutics

Enrolling by invitation

A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)

X-Linked Retinitis Pigmentosa

United States
Almirall, S.A.
Harrison Clinical Research; Almirall Hermal GmbH

Completed

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Austria, Germany, Netherlands, Poland
Poznan University of Medical Sciences

Recruiting

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery

Spinal Stenosis | Erector Spinae Plane Block | Spinal Fusion | Spine Disease

Poland
Idera Pharmaceuticals, Inc.

Completed

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis | Actively Extending Plaque Psoriasis

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis (MATURE)

Plaque Psoriasis

Spain, Germany, United States, Iceland, Canada, Poland
Galapagos NV

Completed

A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Poland, Slovakia, Bulgaria
DBV Technologies

Completed

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy (VIPES)

Peanut Allergy

United States, Netherlands, France, Canada, Poland
Łukasz Krzych

Completed

Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia

Pain, Postoperative | Surgery | Abdominal Aorta Aneurysm | Abdominal Aorta Atheroma

Poland
Therapeutics, Inc.

Completed

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)

Plaque Psoriasis

United States
NightstaRx Ltd, a Biogen Company

Completed

Natural History of the Progression of X-Linked Retinitis Pigmentosa (XOLARIS)

X-Linked Retinitis Pigmentosa

United States, France, United Kingdom, Finland, Netherlands, Germany, Canada
Centocor, Inc.

Terminated

A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa

Retinitis Pigmentosa

United States
ReNeuron Limited

Active, not recruiting

Safety and Tolerability of hRPC in Retinitis Pigmentosa (hRPCRP)

Retinitis Pigmentosa

United States, United Kingdom, Spain
Maruho Europe Limited
Maruho Co., Ltd.

Completed

Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients

Plaque Psoriasis

Germany, Austria, Bulgaria, Hungary, Lithuania, Poland
Biocon Biologics Inc.
MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. Ltd

Completed

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Moderate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis

Bulgaria, Czechia, Estonia, Poland
Erasmus Medical Center

Recruiting

Addition of FFRct in the Diagnostic Pathway of Patients With Stable Chest Pain (Fusion)

Chest Pain | Epicardial Plaques

Netherlands
QLT Inc.

Completed

Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT

Leber Congenital Amaurosis (LCA) | Retinitis Pigmentosa (RP)

United States, Canada, Denmark, Germany, Netherlands, Switzerland, United Kingdom
Akros Pharma Inc.

Completed

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis (IMPACT-PS)

Skin Diseases | Psoriasis | Plaque Psoriasis

United States, Canada, Poland
Eli Lilly and Company

Completed

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Puerto Rico, United States, Germany, Poland, Japan, Canada
Alvotech Swiss AG

Completed

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Poland, Georgia, Estonia, Ukraine
NightstaRx Ltd, a Biogen Company

Enrolling by invitation

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa (SOLSTICE)

Choroideremia | X-Linked Retinitis Pigmentosa

United States, United Kingdom, Netherlands, Germany, France, Brazil, Canada, Denmark, Finland
ProQR Therapeutics

Active, not recruiting

A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene (AURORA)

Eye Diseases | Retinitis | Eye Diseases, Hereditary | Retinal Dystrophies | Vision Disorders | Retinal Disease | Autosomal Dominant Retinitis Pigmentosa | Vision Tunnel

United States
Bioeq GmbH

Completed

A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis (VESPUCCI)

Plaque Psoriasis

Poland, Estonia, Ukraine, Georgia
UCB Biopharma SRL

Active, not recruiting

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis (BE CONNECTED)

Moderate to Severe Plaque Psoriasis

United States, Canada, Germany, Poland
Mayne Pharma International Pty Ltd

Completed

Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis

Plaque Psoriasis

United States, Poland, Ukraine, Georgia
Foundation Fighting Blindness
United States Department of Defense

Completed

Trial of Oral Valproic Acid for Retinitis Pigmentosa (VPA)

Retinitis Pigmentosa

United States
Evelo Biosciences, Inc.

Completed

A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Psoriasis | Plaque Psoriasis

United Kingdom, Hungary, Poland, United States
Alvotech Swiss AG

Completed

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Poland, Georgia, Iceland, Russian Federation, Ukraine
UCB Biopharma S.P.R.L.

Completed

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) (CIMPASI-2)

Psoriasis | Plaque Psoriasis

United States, Austria, Canada, Poland
UCB Biopharma SRL

Completed

A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque Psoriasis

United States, Canada
Aimmune Therapeutics, Inc.

Completed

Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) (RAMSES)

Peanut Allergy

United States, Canada

Clinical Trials on Lichen Planus Pigmentosus in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations